Steve Cohen's Point72 Asset Management fully exited its position in medical device company Teleflex Incorporated (TFX) during the second quarter of 2026. According to the firm's required quarterly disclosure, it sold all 677,310 shares, a stake previously valued at approximately $81.01 million. Teleflex is a global provider of medical technologies for critical care and surgical applications.
This trade was revealed in an SEC 13F filing dated August 14, 2026, which details the investment firm's holdings as of June 30, 2026. Due to the delayed nature of these reports, the transactions occurred at an undisclosed time in the second quarter. During that period, Teleflex reported its financial results, which included strong performance in its vascular and surgical businesses but also challenges with a recent acquisition.